MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-06-2026
Country |
 USA |
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
199 M |
Market Cap[1] |
$ 11.9 B |
EBITDA (LTM) |
$ 1.04 B |
P/E (LTM) |
28.89 |
P/S (LTM) |
3.01 |
EPS (LTM) |
2.12 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | USA |
 |
ICU Medical
ICUI
|
$ 126.43 | 2.73 % | $ 3.12 B | Nasdaq Global Select Market,SPB | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
iRhythm Technologies
IRTC
|
$ 120.66 | -3.37 % | $ 3.86 B | Nasdaq Global Select Market,SPB | USA |
 |
Repro Med Systems
KRMD
|
$ 4.2 | -5.41 % | $ 194 M | Nasdaq Capital Market | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | USA |
 |
LeMaitre Vascular
LMAT
|
$ 107.94 | 0.03 % | $ 2.44 B | Nasdaq Global Market,SPB | USA |
 |
Alcon
ALC
|
$ 62.56 | -2.07 % | $ 40.4 B | NYSE |  Schweiz |
 |
Masimo Corporation
MASI
|
$ 178.31 | -0.11 % | $ 9.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | USA |
 |
Envista Holdings Corporation
NVST
|
$ 24.24 | -0.21 % | $ 4.07 B | NYSE | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | USA |
 |
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | USA |
 |
electroCore
ECOR
|
$ 6.41 | 2.23 % | $ 54.4 K | Nasdaq Global Select Market | USA |
 |
Haemonetics Corporation
HAE
|
$ 55.12 | 1.38 % | $ 2.77 B | NYSE,SPB | USA |
 |
STERIS plc
STE
|
$ 207.45 | -2.92 % | $ 20.4 B | NYSE,SPB | USA |
 |
STAAR Surgical Company
STAA
|
$ 26.69 | -2.16 % | $ 1.32 B | Nasdaq Global Market,SPB | USA |
 |
Teleflex Incorporated
TFX
|
$ 133.06 | 1.05 % | $ 5.94 B | NYSE,SPB | USA |
 |
Intuitive Surgical
ISRG
|
$ 450.06 | -0.76 % | $ 161 B | Nasdaq Global Select Market,SPB | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | USA |
 |
Glaukos Corporation
GKOS
|
$ 133.52 | -0.47 % | $ 6.47 B | NYSE,SPB | USA |
 |
InfuSystem Holdings
INFU
|
$ 8.41 | -6.24 % | $ 174 M | NYSE American | USA |
 |
Microbot Medical
MBOT
|
$ 2.13 | - | $ 97.5 M | Nasdaq Global Select Market |  Israel |
 |
Milestone Scientific
MLSS
|
$ 0.46 | -2.56 % | $ 37.7 M | NYSE American | USA |
 |
Merit Medical Systems
MMSI
|
$ 61.27 | -1.7 % | $ 3.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Utah Medical Products
UTMD
|
$ 65.35 | -0.08 % | $ 212 M | Nasdaq Global Select Market | USA |
 |
West Pharmaceutical Services
WST
|
$ 325.92 | 1.21 % | $ 23.6 B | NYSE,SPB | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 11.0 | 0.36 % | $ 2.19 B | Nasdaq Global Select Market,SPB | USA |
 |
Pulse Biosciences
PLSE
|
$ 19.08 | -2.6 % | $ 1.29 B | Nasdaq Global Select Market | USA |
 |
Retractable Technologies
RVP
|
$ 0.7 | -1.13 % | $ 21 M | NYSE American | USA |
 |
Pro-Dex
PDEX
|
$ 59.27 | 3.22 % | $ 195 M | Nasdaq Global Select Market | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | USA |
 |
BioLife Solutions
BLFS
|
$ 22.04 | -4.67 % | $ 1.05 B | Nasdaq Global Select Market | USA |
 |
Stereotaxis
STXS
|
$ 1.9 | - | $ 173 M | NYSE American | USA |
 |
Baxter International
BAX
|
$ 17.99 | 2.74 % | $ 9.23 B | NYSE,SPB | USA |
 |
ResMed
RMD
|
$ 206.76 | -0.06 % | $ 30.2 B | NYSE,SPB | USA |
 |
AtriCure
ATRC
|
$ 26.28 | -5.47 % | $ 1.25 B | Nasdaq Global Market,SPB | USA |
 |
Harvard Bioscience
HBIO
|
$ 6.9 | 1.55 % | $ 306 M | Nasdaq Global Market | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | USA |
 |
AngioDynamics
ANGO
|
$ 11.2 | -0.62 % | $ 458 M | Nasdaq Global Select Market | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 149.43 | -2.5 % | $ 43 B | NYSE,SPB | USA |
 |
Nephros
NEPH
|
$ 3.52 | 8.98 % | $ 37.4 M | Nasdaq Global Select Market | USA |
 |
OraSure Technologies
OSUR
|
$ 3.06 | -2.24 % | $ 225 M | Nasdaq Global Select Market,SPB | USA |
 |
Repligen Corporation
RGEN
|
$ 123.46 | -2.35 % | $ 6.94 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.